Beyond Next Ventures

Beyond Next Ventures, founded in 2014 and based in Tokyo, Japan, is a venture capital firm dedicated to fostering innovation in Japanese science and technology. The firm focuses on supporting motivated entrepreneurs who possess groundbreaking ideas, with the goal of commercializing these innovations to contribute to a better future and society. Beyond Next Ventures invests in a diverse range of sectors, including medtech, healthcare, drug discovery, biotechnology, agriculture, food, digital technology, space, and climate technology, with an emphasis on opportunities in Japan and India.

Akito Arima

Partner

Hashizume Katsuya

Partner

Yuichiro Sano

Manager and Venture Capitalist

Takehiko Sawabe

Principal

101 past transactions

Emium

Seed Round in 2025
Emium operates a dental cloud platform that enhances the digital experience in the dental industry. By combining dental medical technology with digital manufacturing processes, the company offers CAD design and manufacturing services for dental laboratory products. This infrastructure aims to support dental businesses by advancing both dental care and technology, positioning Emium as a key player in the evolving landscape of dental services.

Boston Medical Sciences

Series A in 2025
Boston Medical Sciences conducts research, prevention, and diagnostics procedures to eliminate colorectal cancer deaths.

Rhinoflux

Seed Round in 2024
Rhinoflux is an energy management company that develops efficient thermal management technologies for advanced cooling systems.

Symbiobe

Series A in 2024
Symbiobe is a company that focuses on developing a resource-recycling material production platform aimed at promoting sustainability. By utilizing underexploited natural biomass resources and photosynthetic organisms, the platform offers innovative solutions for greenhouse gas fixation and the production of industrial biopolymers, nitrogen fertilizers, and aquaculture feed. This approach not only enhances the effectiveness of these materials but also supports environmental start-up businesses in obtaining natural and sustainable products. Symbiobe's mission is to advance manufacturing practices globally to ensure a sustainable future for generations to come.

Red Arrow Therapeutics

Seed Round in 2024
Developer of a healthcare technology designed to replace the traditional way of treating cancer treatment. The company aims to transform the traditional therapeutic into a next-generation therapy for cancer diseases by maximizing the drug potency with minimum toxicity, helping the healthcare sector to overcome systemic toxicity and exhibiting strong anti-tumor efficacy in various tumor models both as monotherapy and in combination with immune checkpoint inhibitors.

Neautech

Seed Round in 2023
Neautech is an application that offers online beauty experiences as well as influences beauty products.

AlgaleX

Seed Round in 2023
AlgaleX is a company focused on transforming discarded food waste into valuable ingredients, particularly plant-based proteins. By employing algae fermentation technology, AlgaleX harnesses unused and underutilized resources, including food residues and liquid waste, to cultivate algae and microorganisms. This innovative approach allows for the production of sustainable products, contributing to waste reduction and promoting environmentally friendly practices within the food industry.

Sakana Dream

Seed Round in 2023
SAKANA Dream develops unique farmed fish species by leveraging an innovative breeding technology "Surrogate Broodstock Technology". The company selects outstanding fish from over 4,000 species living in Japan and produces remarkable hybrid fish which have both great taste and high productivity.

Umami United

Seed Round in 2023
UMAMI UNITED is Japanese inspired plant-based food brand.We are willing to enrich the alt-protein market with unique and innovative Japanese ingredients. Our products are packed full of UMAMI flavor which provides an intense and savory flavor. The first product is UMAMI Egg which is made from Konjac powder as main ingredient.

Olive Union

Venture Round in 2023
Olive Union is an organization that specializes in smart sound algorithms and provides the next-generation hearing solution. It concentrates on hearing interactions and intertwines everyday products with the latest technologies. Its purpose is to combat the two impairments of hearing aids, price, and social perception, and eliminate “hearing impairment.” It was founded in 2016 and is headquartered in Tokyo, Japan.

BiPSEE

Venture Round in 2023
BiPSEE is a medical XR company based in Tokyo, Japan, specializing in the development of virtual and augmented reality solutions aimed at alleviating anxiety and pain in children during medical procedures. By integrating innovative technologies like AR and VR, BiPSEE offers treatment support that enhances children's self-efficacy in various healthcare settings, including dentistry, pediatrics, and dermatology. The company employs one-button dentistry and medicine techniques to create calming environments that can be used both in outpatient and hospitalized situations. Additionally, BiPSEE incorporates advanced cognitive-behavioral therapy methods to provide therapeutic experiences designed to help users change their perspectives and improve their mental well-being.

Fermelanta

Seed Round in 2023
Fermelanta is a biotechnology company specializing in the production of rare plant-based ingredients through microbial fermentation. It focuses on developing plant secondary metabolites by engineering cells to create biosynthetic pathways for target molecules using gene transfer and disruption techniques. The company aims to produce beneficial plant-based chemicals for various applications, including medicines, cosmetics, and dietary supplements. By utilizing this innovative fermentation process, Fermelanta contributes to the development of sustainable and environmentally friendly chemicals, promoting both human health and ecological well-being.

EF Polymer

Series A in 2023
EF Polymer is an agricultural firm focused on addressing water scarcity through innovative solutions. The company has developed "Fasal Amrit," an eco-friendly water retention natural polymer made from organic waste, including materials like citrus fruits and banana peels. This polymer can absorb up to 300 times its weight in water and retain it for 10-12 days, significantly reducing irrigation water needs by 30-40%. Additionally, it minimizes fertilizer loss by 10-20%, allowing for a reduction in fertilizer use by 40-50%. "Fasal Amrit" is free from chemicals and pollution, and it is 100% biodegradable within 5-6 months after application. Its micronutrient content supports optimal crop growth, enabling farmers to lower their water and fertilizer costs by 20-40% and potentially increase crop yields by 10-20%. The product is versatile, suitable for various applications, from in-house plants to gardens, and is particularly beneficial in areas where regular watering is challenging.

Curreio

Series A in 2023
Curreio is a biotechnology company focused on drug discovery through advanced structural analysis using cryo-electron microscopy. The company offers a platform that enables researchers to observe biological structures in their native state by freezing them without staining. This innovative approach facilitates the discovery and analysis of potential life-saving drugs, leveraging structural analysis techniques to enhance the drug development process. By providing cutting-edge technology, Curreio aims to improve the efficiency and effectiveness of drug discovery efforts in the biotechnology sector.

Secai Marche

Series A in 2023
Secai Marche Inc. operates an online marketplace that connects small-scale farmers with restaurants and consumers, facilitating direct purchases of high-quality food products. Founded in 2018 and headquartered in Tokyo, Japan, with an additional office in Kuala Lumpur, Malaysia, the platform enhances the economic viability of small farms by improving their access to markets. Secai Marche offers services that include sourcing, order processing, payment, and delivery, allowing farmers to sell seasonal and regionally sourced ingredients directly to chefs and businesses. The company's mission is to promote sustainable farming practices and ensure that farmers can achieve a profitable livelihood while providing consumers with fresh and delicious food options.

Myelin Foundry

Series A in 2023
Myelin Foundry is a deep tech startup based in Bengaluru, Karnataka, established in January 2019. The company specializes in developing artificial intelligence algorithms that utilize video, voice, and sensor data to enhance user experiences and optimize industry outcomes. Myelin Foundry's expertise lies in productizing deep learning frameworks, such as convolutional neural networks and generative adversarial networks, with applications spanning media and entertainment, health and wellness, and national security. By focusing on edge AI products, the company aims to transform visual experiences and create personalized outcomes on consumer devices, thereby enabling clients to improve efficiency and reduce costs in content creation and delivery.

Symbiobe

Seed Round in 2022
Symbiobe is a company that focuses on developing a resource-recycling material production platform aimed at promoting sustainability. By utilizing underexploited natural biomass resources and photosynthetic organisms, the platform offers innovative solutions for greenhouse gas fixation and the production of industrial biopolymers, nitrogen fertilizers, and aquaculture feed. This approach not only enhances the effectiveness of these materials but also supports environmental start-up businesses in obtaining natural and sustainable products. Symbiobe's mission is to advance manufacturing practices globally to ensure a sustainable future for generations to come.

The Ethical Spirits

Venture Round in 2022
The Ethical Spirits is a craft gin brand that focuses on sustainability by utilizing sake lees from Kuramae, Tokyo, and leftover beer, particularly in response to the challenges posed by the pandemic. The company aims to create a circular economy in the alcoholic beverage industry by producing not only gin but also whiskey and other related products. By offering a monthly subscription service, Ethical Spirits allows consumers to enjoy a variety of flavored drinks while promoting ethical practices in production. The brand aspires to establish itself as a long-lasting presence in the spirits market, aligning quality with environmental responsibility.

Generic Aadhaar

Seed Round in 2022
Generic Aadhaar is a retail company based in Thane, India, that specializes in the sale of generic medicines, both through physical outlets and online platforms. Founded in 2018, the company sources its products directly from government-approved manufacturing sites, allowing it to minimize costs associated with brand promotion. By doing so, Generic Aadhaar aims to provide affordable pricing for its customers, particularly targeting senior citizens and pension holders. The company also offers a medicine delivery service, ensuring that customers receive their medications at home without compromising on quality.

LIFESCAPES

Seed Round in 2022
LIFESCAPES is a researcher and manufacturer of brain-computer interface equipment. LIFESCAPES aims to use BMI technology to help stroke patients solve problems and improve their quality of life. LIFESCAPES uses BMI to bring out the plasticity of the brain and help people who are in trouble to be free of their limitations and to live their lives normally.

Grand Green

Series B in 2022
GRA&GREEN is an agribio startup that creates the next era of food and agriculture. They produce crops using the same amount of space and resources. The company aims to maximize output through a variety of approaches, such as increasing crop yields and improving storage stability. The goal of GRA&GREEN is to increase crops' use of fertilizer while increasing their resistance to pests and environmental challenges.

BigHaat

Series B in 2022
BigHaat is an online platform based in Bangalore, India, focused on providing farmers with access to quality agricultural products, including seeds, plant protection, plant nutrition, and agri-implements. Launched in 2015, BigHaat collaborates with various seed suppliers across the country to offer a transparent and competitive marketplace for seed buyers. The platform facilitates online product listings and connects buyers with suppliers, ensuring post-sale support and a seamless user experience. By bridging the gap between sellers and buyers in the agricultural sector, BigHaat enhances operational efficiency and productivity for all stakeholders involved in the agri-value chain, ultimately helping farmers improve their yields and income.

IntegriCulture

Series A in 2022
IntegriCulture Inc., founded in 2015 and based in Bunkyo, Japan, specializes in the development of cellular agriculture products, including clean meat and clean foie gras. The company focuses on improving sustainability and food security while addressing public health issues associated with traditional meat production. IntegriCulture has created a patented large-scale cell culture system that allows for the cultivation of a wide range of cells without the need for expensive growth factors, making clean meat more affordable for consumers. Through its innovative technology, IntegriCulture aims to revolutionize the food industry and promote a more sustainable future.

Koala Tech

Venture Round in 2021
Koala Tech Inc. is an innovative high-tech startup company, whose goal is to pioneer practical applications of the world's first organic semiconductor laser diode that has been realized in the Center for Organic Photonics and Electronics Research (OPERA) at Kyushu University.

Curreio

Venture Round in 2021
Curreio is a biotechnology company focused on drug discovery through advanced structural analysis using cryo-electron microscopy. The company offers a platform that enables researchers to observe biological structures in their native state by freezing them without staining. This innovative approach facilitates the discovery and analysis of potential life-saving drugs, leveraging structural analysis techniques to enhance the drug development process. By providing cutting-edge technology, Curreio aims to improve the efficiency and effectiveness of drug discovery efforts in the biotechnology sector.

The Ethical Spirits

Seed Round in 2021
The Ethical Spirits is a craft gin brand that focuses on sustainability by utilizing sake lees from Kuramae, Tokyo, and leftover beer, particularly in response to the challenges posed by the pandemic. The company aims to create a circular economy in the alcoholic beverage industry by producing not only gin but also whiskey and other related products. By offering a monthly subscription service, Ethical Spirits allows consumers to enjoy a variety of flavored drinks while promoting ethical practices in production. The brand aspires to establish itself as a long-lasting presence in the spirits market, aligning quality with environmental responsibility.

Acompany

Seed Round in 2021
Acompany specializes in privacy protection solutions that focus on secure computing. The company has developed cryptographic technology aimed at addressing the tension between privacy protection and data utilization. By enabling the analysis of encrypted data across various attributes, Acompany employs secure multi-party computation through a secret-sharing method. This innovative approach allows clients to leverage sensitive data across legal, technological, and business domains while ensuring privacy. Acompany is committed to fostering a safe and secure data society by utilizing advanced privacy technology to tackle social issues.

AIBIOS

Seed Round in 2021
AIBIOS has designed and developed a series of novel small molecules which modulate both the innate (macrophages) and adaptive immune system to treat therapeutic indications of Gastroenterology, Respiratory, and Neurological diseases.

Tayo

Seed Round in 2021
Tayo is a social problem-solving start-up company that tackles issues in the research industry. They serve domestic, overseas research institutions, and national universities. Their services include consulting services related to public relations, recruitment platforms, and internet advertising.

Secai Marche

Seed Round in 2021
Secai Marche Inc. operates an online marketplace that connects small-scale farmers with restaurants and consumers, facilitating direct purchases of high-quality food products. Founded in 2018 and headquartered in Tokyo, Japan, with an additional office in Kuala Lumpur, Malaysia, the platform enhances the economic viability of small farms by improving their access to markets. Secai Marche offers services that include sourcing, order processing, payment, and delivery, allowing farmers to sell seasonal and regionally sourced ingredients directly to chefs and businesses. The company's mission is to promote sustainable farming practices and ensure that farmers can achieve a profitable livelihood while providing consumers with fresh and delicious food options.

Libero Thera

Venture Round in 2021
LiberoThera provides drug discovery research and development services. It focuses on making drugs with GPCRs for membrane proteins. LiberoThera was founded in 2018 and is located in Tokyo.

Myelin Foundry

Seed Round in 2021
Myelin Foundry is a deep tech startup based in Bengaluru, Karnataka, established in January 2019. The company specializes in developing artificial intelligence algorithms that utilize video, voice, and sensor data to enhance user experiences and optimize industry outcomes. Myelin Foundry's expertise lies in productizing deep learning frameworks, such as convolutional neural networks and generative adversarial networks, with applications spanning media and entertainment, health and wellness, and national security. By focusing on edge AI products, the company aims to transform visual experiences and create personalized outcomes on consumer devices, thereby enabling clients to improve efficiency and reduce costs in content creation and delivery.

EF Polymer

Seed Round in 2021
EF Polymer is an agricultural firm focused on addressing water scarcity through innovative solutions. The company has developed "Fasal Amrit," an eco-friendly water retention natural polymer made from organic waste, including materials like citrus fruits and banana peels. This polymer can absorb up to 300 times its weight in water and retain it for 10-12 days, significantly reducing irrigation water needs by 30-40%. Additionally, it minimizes fertilizer loss by 10-20%, allowing for a reduction in fertilizer use by 40-50%. "Fasal Amrit" is free from chemicals and pollution, and it is 100% biodegradable within 5-6 months after application. Its micronutrient content supports optimal crop growth, enabling farmers to lower their water and fertilizer costs by 20-40% and potentially increase crop yields by 10-20%. The product is versatile, suitable for various applications, from in-house plants to gardens, and is particularly beneficial in areas where regular watering is challenging.

Olive Union

Series B in 2021
Olive Union is an organization that specializes in smart sound algorithms and provides the next-generation hearing solution. It concentrates on hearing interactions and intertwines everyday products with the latest technologies. Its purpose is to combat the two impairments of hearing aids, price, and social perception, and eliminate “hearing impairment.” It was founded in 2016 and is headquartered in Tokyo, Japan.

Alchemedicine

Series A in 2021
Alchemedicine is a the world in drug discovery with unique technologies and ideas Innovating new drug candidates for diseases with high unmet medical needs.

MEDITA

Venture Round in 2021
Medita is a technology company focused on the development of medical equipment, health consulting, and welfare services. It specializes in a body temperature management application that helps users monitor and manage their physical conditions related to body temperature fluctuations. This application is designed to accurately track biorhythms and supports the early detection of infertility and gynecological diseases. By empowering adult women to gain insights into their physical and mental health, Medita promotes a proactive approach to managing wellness and encourages healthier lifestyle choices.

Imbesideyou

Seed Round in 2021
Imbesideyou is a digital platform that intends to improve the quality of online communication with multimodal AI analytic solutions.

Gryllus

Series A in 2020
Gryllus is a company that specializes in cricket breeding management and the production of edible cricket powder for use in snacks and various food products. By utilizing a unique automatic cricket breeding system, Gryllus aims to optimize the growth of crickets, which are rich in protein and require significantly less food and water compared to traditional livestock. This innovative approach not only enhances the nutritional value of the products but also promotes sustainable food practices. Gryllus is committed to integrating crickets into the food supply, leveraging their potential to provide a nutritious and eco-friendly protein source.

Gojo & Company

Series D in 2020
Gojo & Company Inc. is a holding company based in Tokyo, Japan, that focuses on enhancing financial inclusion for underserved communities. Founded in 2014, the company operates through subsidiaries, including Microfinance Delta International and Sejaya Micro Credit, providing microfinance services. Gojo partners with financial service providers across 13 countries in Southeast Asia, South Asia, Central Asia, the Caucasus, and Africa. The company aims to empower individuals to improve their circumstances and achieve financial independence by ensuring access to quality and affordable financial services in developing regions.

Anaut

Seed Round in 2020
Anaut Inc. is a technology company based in Yokohama City, Japan, founded in 2020, that specializes in developing artificial intelligence software for surgical support. The company has created a surgery-support AI system that analyzes complex internal anatomical information in real time, aiding surgeons in visual perception during operations. By leveraging deep learning techniques on a vast array of surgical videos, Anaut aims to enhance the accuracy of its system, broaden the range of surgical applications, and facilitate cross-sectional analysis of surgeries within the chest, abdomen, and pelvic regions. This innovative approach is designed to improve patient safety and manage surgical complications effectively.

Connect Japan

Venture Round in 2020
Connect Japan is developing services that connect people.

Regional Fish

Series A in 2020
Regional Fish Inc., founded in 2019 and based in Kyoto, Japan, specializes in the development of advanced breeding technologies for fish using genome editing and artificial intelligence. The company focuses on creating sustainable land-based aquaculture systems that minimize environmental impact, utilizing clean energy and organic waste nitrogen. By leveraging high-speed breeding techniques, Regional Fish aims to enhance the efficiency of the fisheries industry while promoting natural evolution. Through its innovative approach, the company seeks to transform the aquatic industry and provide consumers with genome-edited food options.

BigHaat

Venture Round in 2020
BigHaat is an online platform based in Bangalore, India, focused on providing farmers with access to quality agricultural products, including seeds, plant protection, plant nutrition, and agri-implements. Launched in 2015, BigHaat collaborates with various seed suppliers across the country to offer a transparent and competitive marketplace for seed buyers. The platform facilitates online product listings and connects buyers with suppliers, ensuring post-sale support and a seamless user experience. By bridging the gap between sellers and buyers in the agricultural sector, BigHaat enhances operational efficiency and productivity for all stakeholders involved in the agri-value chain, ultimately helping farmers improve their yields and income.

GigIndia

Seed Round in 2020
GigIndia is a marketplace that provides on-demand work completion for companies through a gig workforce of jobseekers. The startup leverages technologies like machine learning and artificial intelligence for faster turnaround and quality checks.

Biomoneta Research

Seed Round in 2020
Biomoneta is a health tech startup that aims to prevent the transmission of infection in the hospital and the community, and the spread of microbial contamination in commercial and academic laboratories. Our novel, extremely effective air decontamination technology traps and kills bacteria, mold and viruses that contaminate the environment and cause infection and product loss. Our energy efficient devices can be deployed near patient beds in the hospital and home, in biotech laboratories to create local zones of decontamination, and can be integrated into central air handling units to provide building-wide protection.

MabGenesis

Series A in 2020
MabGenesis Inc. is a biopharmaceutical company founded in 2019 and based in Yokohama, Japan. The company specializes in developing therapeutic monoclonal antibody drugs for both humans and animals. MabGenesis utilizes advanced antibody library and isolation technologies to discover fully human and canine/feline antibodies. By providing novel antibody therapeutics, the company aims to alleviate symptoms and enhance the quality of life for individuals suffering from various diseases, as well as for their companion animals. MabGenesis also offers licensing opportunities for pharmaceutical companies, thereby contributing to new drug development in the healthcare industry.

IntegriCulture

Series A in 2020
IntegriCulture Inc., founded in 2015 and based in Bunkyo, Japan, specializes in the development of cellular agriculture products, including clean meat and clean foie gras. The company focuses on improving sustainability and food security while addressing public health issues associated with traditional meat production. IntegriCulture has created a patented large-scale cell culture system that allows for the cultivation of a wide range of cells without the need for expensive growth factors, making clean meat more affordable for consumers. Through its innovative technology, IntegriCulture aims to revolutionize the food industry and promote a more sustainable future.

MabGenesis

Seed Round in 2020
MabGenesis Inc. is a biopharmaceutical company founded in 2019 and based in Yokohama, Japan. The company specializes in developing therapeutic monoclonal antibody drugs for both humans and animals. MabGenesis utilizes advanced antibody library and isolation technologies to discover fully human and canine/feline antibodies. By providing novel antibody therapeutics, the company aims to alleviate symptoms and enhance the quality of life for individuals suffering from various diseases, as well as for their companion animals. MabGenesis also offers licensing opportunities for pharmaceutical companies, thereby contributing to new drug development in the healthcare industry.

Lil'Goodness

Seed Round in 2020
Lil'Goodness is a children-focused food and nutrition startup. We engage with moms through our app and our social pages.

Precision

Venture Round in 2020
Precision is a Medical care and the social situation surrounding it are changing dramatically, and the amount of information and work required at medical sites is increasing at an accelerating rate.

Grand Green

Series A in 2020
GRA&GREEN is an agribio startup that creates the next era of food and agriculture. They produce crops using the same amount of space and resources. The company aims to maximize output through a variety of approaches, such as increasing crop yields and improving storage stability. The goal of GRA&GREEN is to increase crops' use of fertilizer while increasing their resistance to pests and environmental challenges.

Koala Tech

Venture Round in 2020
Koala Tech Inc. is an innovative high-tech startup company, whose goal is to pioneer practical applications of the world's first organic semiconductor laser diode that has been realized in the Center for Organic Photonics and Electronics Research (OPERA) at Kyushu University.

Sonoligo

Venture Round in 2019
Sonoligo Inc. is an online platform based in Kariya, Japan, founded in 2018, that offers access to cultural events and media content through a monthly subscription model. The platform enables users to participate in real events and access online experiences and video content related to music, sports, and art. By providing a flat-rate service, Sonoligo caters to individuals of all age groups, offering a variety of monthly plans to suit diverse interests in cultural activities.

Alchemedicine

Venture Round in 2019
Alchemedicine is a the world in drug discovery with unique technologies and ideas Innovating new drug candidates for diseases with high unmet medical needs.

Vitaars

Venture Round in 2019
Vitaars is a Japanese company that specializes in providing remote medical support for Intensive Care Units (ICUs). Headquartered in Kobe, the company addresses the shortage of intensivists in hospitals by offering a tele-intensive care service known as "RELIEVE." This system allows a team of intensivists and certified intensive care nurses to provide 24/7 consultations and support for the treatment of critically ill patients. In addition to direct patient care, Vitaars offers training for doctors and nurses in intensive and emergency care, ensuring that medical personnel are equipped with the latest knowledge and techniques. By facilitating remote consultations and improving the skills of healthcare providers, Vitaars enhances the quality of critical care available to patients across various regions and facilities.

Novenine

Venture Round in 2019
Novenine, Inc., founded in 2018 and headquartered in Osaka, Japan, specializes in oral health care consultation services and the distribution of related products. The company develops and operates innovative dental care solutions, including smart toothbrushes and a teleconsultation platform that connects patients with dental specialists. By focusing on prevention, Novenine enables patients to seek early assistance and take proactive measures against serious dental diseases. Its offerings reflect a commitment to enhancing oral health management through technology and expert guidance.

POL

Series A in 2019
POL is creating a platform that maximizes the possibilities of researchers. It is a laboratory that is a place where innovative science and technology are created that greatly advances society. Its first project "LabBase" would like to create a society that can solve problems in job hunting for science-based human resources, issues of companies wanting to adopt them, issues faced by laboratories, and so that science-based human resources can be used more effectively.

iCare

Venture Round in 2019
iCare is a health consulting company that specializes in the development and operation of health management systems. It offers a leading health and labor cloud solution in Japan, catering primarily to small and medium-sized enterprises facing workforce challenges, as well as large enterprises expanding globally. The company's healthcare management platform is designed to streamline mental care services for employees by aggregating essential health information, such as health check results, stress assessments, overtime hours, and health consultations, all stored in the cloud. This enables businesses to alleviate the burden of managing employee health effectively.

FullDepth

Venture Round in 2019
FullDepth is a company focused on developing marine drones that facilitate underwater monitoring. These drones integrate with marine navigation technology to monitor and capture various aspects of aquatic life. They communicate data to connected devices and provide infiltration information accessible through a cloud service. This enables users to observe and study marine life for both educational and recreational purposes.

Aillis

Venture Round in 2019
Aillis specializes in the development of testing methods for Influenza using artificial intelligence technology. The company mainly focuses on new methods of diagnosing influenza. The company was founded in 2017.

Photo electron Soul

Venture Round in 2019
Photo Electron Soul Inc. is a Japanese company based in Nagoya, established in July 2015, that specializes in the development and management of photocathode electron beam systems. The company focuses on creating advanced electron beam generating apparatuses that leverage semiconductor photocathode technology. These innovations aim to enhance the capabilities of industrial equipment, including electron microscopes, semiconductor manufacturing and inspection tools, and metal 3D printers. By improving electron beam performance with attributes such as pulse structure, low dispersion, and high current, Photo Electron Soul aims to facilitate fine observation and processing across various sectors, including science, materials, and electronics. The company's mission centers on transforming the fields of observation and processing through cutting-edge technology.

Academist

Series A in 2019
Academist, Inc. is a Tokyo-based company that operates a crowdfunding platform dedicated to acquiring research funds. Founded in April 2013, Academist enables researchers to raise expenses for their projects by connecting them with a broad community of supporters through the internet. The platform allows users to provide funds via one-time or monthly contributions, thereby facilitating direct support for various research themes and initiatives. Through its services, Academist aims to enhance the academic landscape by fostering connections between researchers and potential financial backers.

miup

Venture Round in 2018
Miup is a healthcare is an area where you can fully benefit from the pioneer by acquiring a large amount of vital data. At first, we will strive to spread prevention and medical care and collect vital data in emerging countries, and grow into an irreplaceable entity by learning data from machines. And deliver straight medical care to people all over the world. This is an overwhelming advantage over developed and highly vested countries. To collect a large amount of data, and to improve diagnosis assistance and risk prediction accuracy, build a healthcare miup cycle such as health management, diagnosis assistance, and prevention. We aim for a wellness ecosystem that can utilize data for the next generation.

Metcela

Series A in 2018
Metcela Inc. is a clinical-stage biotechnology company focused on developing innovative therapies for cardiac diseases. Founded in 2016 and based in Kawasaki, Japan, Metcela specializes in fibroblast-based treatments, particularly its lead asset, MTC001. This therapy utilizes VCAM-1-positive Cardiac Fibroblasts, which are derived from the patient's own heart cells. Rather than replacing damaged cells, the therapy enhances the body's natural healing processes to repair heart tissue and restore a favorable microenvironment. Through its research and development efforts, Metcela aims to offer patients an effective and affordable alternative for treating heart failure.

QD Laser

Series F in 2018
QD Laser, Inc. specializes in the development and manufacturing of quantum dot semiconductor lasers and wafers, primarily using GaAs substrates. The company produces a variety of laser technologies, including picosecond short-pulse DFB lasers for precision processing and current injection-type lasers in green, yellow-green, and orange for biological applications. Additionally, QD Laser develops quantum dot laser arrays for silicon optical circuits and broadband gain chips for ophthalmic testing equipment. Their products are utilized in diverse sectors such as telecommunications, manufacturing, medicine, and consumer products, addressing applications in silicon photonics, sensing, and precision machining. Established in 2006 and headquartered in Kawasaki, Japan, QD Laser aims to enhance the performance of semiconductor lasers across various industries.

Vitaars

Secondary Market in 2018
Vitaars is a Japanese company that specializes in providing remote medical support for Intensive Care Units (ICUs). Headquartered in Kobe, the company addresses the shortage of intensivists in hospitals by offering a tele-intensive care service known as "RELIEVE." This system allows a team of intensivists and certified intensive care nurses to provide 24/7 consultations and support for the treatment of critically ill patients. In addition to direct patient care, Vitaars offers training for doctors and nurses in intensive and emergency care, ensuring that medical personnel are equipped with the latest knowledge and techniques. By facilitating remote consultations and improving the skills of healthcare providers, Vitaars enhances the quality of critical care available to patients across various regions and facilities.

Mirtel

Venture Round in 2018
MiRTeL is a healthcare technology company that specializes in providing innovative solutions for early disease detection and personalized healthcare. The company offers clinical and gene testing services aimed at enhancing health examinations. Its laboratory testing focuses on detecting exosomes and genetic disorders, which helps healthcare organizations improve patient longevity while reducing medical costs. By facilitating early detection of cancer and pre-illness conditions, MiRTeL contributes to more effective healthcare outcomes and supports research initiatives in the medical field.

Xenoma

Venture Round in 2018
Xenoma, Inc. is a Tokyo-based company specializing in the development of e-skin, a platform for wearable electronic apparel that monitors various physiological functions such as motion, breathing, pressure, and body temperature. As a spin-off from the University of Tokyo's Someya Group Organic Transistor Lab, Xenoma leverages advancements in organic electronics to create ultrathin and ultraflexible devices that seamlessly integrate with the human body. Their innovative clothing line features highly sensitive motion sensors capable of tracking body movement and posture, facilitating the collection of valuable health data. This data can be used to enhance healthcare solutions by combining it with big data analytics, while their products remain comfortable, durable, and machine washable for everyday use.

Susmed

Venture Round in 2018
Susmed is a software company focused on developing therapeutic applications and clinical trial systems, utilizing blockchain technology to enhance their offerings. The company specializes in creating medical equipment and software systems that facilitate the collection and distribution of medical information. By integrating innovative technology into healthcare, Susmed aims to improve the efficiency and effectiveness of clinical trials and therapeutic solutions.

IntegriCulture

Seed Round in 2018
IntegriCulture Inc., founded in 2015 and based in Bunkyo, Japan, specializes in the development of cellular agriculture products, including clean meat and clean foie gras. The company focuses on improving sustainability and food security while addressing public health issues associated with traditional meat production. IntegriCulture has created a patented large-scale cell culture system that allows for the cultivation of a wide range of cells without the need for expensive growth factors, making clean meat more affordable for consumers. Through its innovative technology, IntegriCulture aims to revolutionize the food industry and promote a more sustainable future.

Lily MedTech

Series A in 2018
Lily MedTech Inc. is a Tokyo-based company founded in 2016 that specializes in developing and manufacturing medical devices for breast cancer diagnosis. The company focuses on creating innovative ultrasound diagnostic imaging equipment, specifically a ring echo device that utilizes a ring-type ultrasonic transducer to produce 3D images of the entire breast. This approach allows for a non-deforming examination, which minimizes pain and reduces exposure risks for patients during the diagnostic process. Through its advancements in breast ultrasound technology, Lily MedTech aims to enhance the accuracy and comfort of breast cancer detection for both patients and healthcare providers.

Photo electron Soul

Venture Round in 2018
Photo Electron Soul Inc. is a Japanese company based in Nagoya, established in July 2015, that specializes in the development and management of photocathode electron beam systems. The company focuses on creating advanced electron beam generating apparatuses that leverage semiconductor photocathode technology. These innovations aim to enhance the capabilities of industrial equipment, including electron microscopes, semiconductor manufacturing and inspection tools, and metal 3D printers. By improving electron beam performance with attributes such as pulse structure, low dispersion, and high current, Photo Electron Soul aims to facilitate fine observation and processing across various sectors, including science, materials, and electronics. The company's mission centers on transforming the fields of observation and processing through cutting-edge technology.

iCare

Venture Round in 2018
iCare is a health consulting company that specializes in the development and operation of health management systems. It offers a leading health and labor cloud solution in Japan, catering primarily to small and medium-sized enterprises facing workforce challenges, as well as large enterprises expanding globally. The company's healthcare management platform is designed to streamline mental care services for employees by aggregating essential health information, such as health check results, stress assessments, overtime hours, and health consultations, all stored in the cloud. This enables businesses to alleviate the burden of managing employee health effectively.

Riverfield

Series B in 2017
Riverfield is a Japanese start-up that develops robotic technology for use in the healthcare sector. Jafco has invested in robotics before. Earlier this year, portfolio company Cyberdyne, a robot suit maker, raised $8

Xenoma

Series A in 2017
Xenoma, Inc. is a Tokyo-based company specializing in the development of e-skin, a platform for wearable electronic apparel that monitors various physiological functions such as motion, breathing, pressure, and body temperature. As a spin-off from the University of Tokyo's Someya Group Organic Transistor Lab, Xenoma leverages advancements in organic electronics to create ultrathin and ultraflexible devices that seamlessly integrate with the human body. Their innovative clothing line features highly sensitive motion sensors capable of tracking body movement and posture, facilitating the collection of valuable health data. This data can be used to enhance healthcare solutions by combining it with big data analytics, while their products remain comfortable, durable, and machine washable for everyday use.

Repertoire Genesis

Series C in 2017
Repertoire Genesis supports the realization of new diagnostic methods / therapeutic methods related to personalized medicine by utilizing T cell / B cell receptor retort analysis and neo-epithelial analysis.

Ambient Intelligence Technology

Seed Round in 2017
FullDepth provides industrial underwater drone services. They are things related to the deep sea, such as the state of deep sea exploration and images of living things.

FullDepth

Venture Round in 2017
FullDepth is a company focused on developing marine drones that facilitate underwater monitoring. These drones integrate with marine navigation technology to monitor and capture various aspects of aquatic life. They communicate data to connected devices and provide infiltration information accessible through a cloud service. This enables users to observe and study marine life for both educational and recreational purposes.

POL

Seed Round in 2017
POL is creating a platform that maximizes the possibilities of researchers. It is a laboratory that is a place where innovative science and technology are created that greatly advances society. Its first project "LabBase" would like to create a society that can solve problems in job hunting for science-based human resources, issues of companies wanting to adopt them, issues faced by laboratories, and so that science-based human resources can be used more effectively.

Myoridge

Seed Round in 2017
Myoridge Co. Ltd. is a biotechnology company based in Kyoto, Japan, that focuses on developing innovative solutions for cell differentiation and drug research. Established in 2016, the company specializes in a suspension culture system that facilitates the scalable differentiation of pluripotent cells into cardiomyocytes without the need for proteins, utilizing a novel small-molecule compound. Myoridge produces iPS cell-derived cardiomyocytes and cardiomyocyte fibers, which are characterized by high maturity and purity, offering excellent drug response rates. Their products also include software for analyzing myocardial motion and fluorescence. By employing a protein-free medium for cell culture, Myoridge achieves low production costs and lot-to-lot uniformity while closely approximating the characteristics of mature human cardiomyocytes. This approach supports advancements in regenerative medicine and drug development technologies.

Susmed

Seed Round in 2017
Susmed is a software company focused on developing therapeutic applications and clinical trial systems, utilizing blockchain technology to enhance their offerings. The company specializes in creating medical equipment and software systems that facilitate the collection and distribution of medical information. By integrating innovative technology into healthcare, Susmed aims to improve the efficiency and effectiveness of clinical trials and therapeutic solutions.

CureApp

Series A in 2017
CureApp, Inc., founded in 2014 and based in Tokyo, Japan, specializes in developing mobile applications aimed at treating various health conditions, particularly nicotine addiction. The company's flagship product, a nicotine addiction treatment app, was launched in February 2015 in collaboration with the Division of Pulmonary Medicine at Keio University’s School of Medicine. CureApp is recognized as a prominent player in the digital health sector, focusing on applications that exhibit therapeutic effects against diseases. The company is actively conducting clinical trials to validate the efficacy of its applications. Additionally, CureApp's medical treatment platform allows users to keep daily activity logs, which are analyzed to identify triggers exacerbating their conditions. This technology enables patients to receive personalized guidance in managing lifestyle diseases, addressing health issues that are typically not managed by conventional medications or devices.

Repertoire Genesis

Series B in 2016
Repertoire Genesis supports the realization of new diagnostic methods / therapeutic methods related to personalized medicine by utilizing T cell / B cell receptor retort analysis and neo-epithelial analysis.

OryLab

Venture Round in 2016
Ory Laboratories Inc. is a Tokyo-based company founded in September 2012, specializing in the research, development, manufacturing, and sales of communication technology. The company focuses on creating remote-controlled robots designed to serve as an alter-ego for users. These compact robots are equipped with the ability to communicate and mimic human movements, including the use of hands and neck, all through an internet connection. By addressing the issue of loneliness, OryLab aims to enhance social interaction and connectivity for its users.

Xenoma

Seed Round in 2016
Xenoma, Inc. is a Tokyo-based company specializing in the development of e-skin, a platform for wearable electronic apparel that monitors various physiological functions such as motion, breathing, pressure, and body temperature. As a spin-off from the University of Tokyo's Someya Group Organic Transistor Lab, Xenoma leverages advancements in organic electronics to create ultrathin and ultraflexible devices that seamlessly integrate with the human body. Their innovative clothing line features highly sensitive motion sensors capable of tracking body movement and posture, facilitating the collection of valuable health data. This data can be used to enhance healthcare solutions by combining it with big data analytics, while their products remain comfortable, durable, and machine washable for everyday use.

Elephantech

Seed Round in 2016
Elephantech Inc., founded in January 2014 and based in Tokyo, Japan, specializes in the manufacturing of electronic circuits with a focus on sustainability. The company utilizes innovative metal inkjet printing technology to produce flexible printed circuit boards, employing silver nano ink and electroless copper plating. This advanced manufacturing process allows Elephantech to offer clients cost-effective and environmentally friendly solutions. Additionally, the company develops application products using flexible substrates, further enhancing its commitment to sustainable practices in the electric industry.

CureApp

Seed Round in 2015
CureApp, Inc., founded in 2014 and based in Tokyo, Japan, specializes in developing mobile applications aimed at treating various health conditions, particularly nicotine addiction. The company's flagship product, a nicotine addiction treatment app, was launched in February 2015 in collaboration with the Division of Pulmonary Medicine at Keio University’s School of Medicine. CureApp is recognized as a prominent player in the digital health sector, focusing on applications that exhibit therapeutic effects against diseases. The company is actively conducting clinical trials to validate the efficacy of its applications. Additionally, CureApp's medical treatment platform allows users to keep daily activity logs, which are analyzed to identify triggers exacerbating their conditions. This technology enables patients to receive personalized guidance in managing lifestyle diseases, addressing health issues that are typically not managed by conventional medications or devices.

Volt14 Solutions

Volt14 Solutions specializes in the development of ultra-high performance materials for lithium-ion batteries, focusing on lithium anodes that can significantly enhance battery energy density. Their innovative products can potentially increase energy density by up to 70%, addressing common concerns such as range anxiety and reducing storage costs by nearly 40%. Utilizing a wet chemistry approach, Volt14 enables manufacturers to integrate these advanced anodes into their existing production lines without facing manufacturing bottlenecks. This adaptability allows for seamless implementation across various applications, including automotive, defense, and space systems, positioning Volt14 as a key player in the energy industry.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.